Current cellular theories of carcinogenesis emphasise the multistage nature of cancer in which there is thought to be a causal relation between the accumulation of genetic abnormalities and the clinical and biological behaviour of the tumour (Weinberg, 1991; Fearon and Vogelstein, 1990; Yokota and Sugimura, 1993) . In humans the clearest example is probably the development of colorectal carcinoma, and in the mouse the development of cutaneous squamous cell carcinoma (SCC) and spindle cell carcinoma following topical application of chemical carcinogens (for reviews see Fearon and Vogelstein, 1990; Burns et al., 1991) . Non-melanoma skin cancer (NMSC), the commonest human malignancy in many Caucasian populations (Weinstock, 1994) , offers a number of opportunities for the investigation of the relationship between genetic change and tumour phenotype. The occurrence of a range of different tumour types, all keratinocyte derived and related to ultraviolet radiation (UVR), with markedly different clinical behaviours, and in particular the presence of a number of neoplastic lesions, such as keratoacanthomas (KAs) , that show spontaneous regression are of considerable experimental interest (Rees, 1994) . KAs are a common keratinising squamous neoplasm, classically occurring on the JVR-exposed skin of elderly individuals, which are characterised clinically by a period of rapid growth over a 4-12 week period followed by spontaneous involution (Schwartz, 1994; Straka and GrantKels, 1991; Ghadially and Ghadially, 1993) . Histologically KAs resemble SCCs, and although on occasions the histological differentiation from SCC may be difficult their biologically benign course allows clear differentiation (Straka and Grant-Kels, 1991; Schwartz, 1994) . A number of pathogenic abnormalities have been described in KAs, including H-ras mutations, aneuploidy, altered p53 immunostaining and the presence of human papillomavirus (HPV) DNA (Corominas et al., 1989; Newton et al., 1987; Herzberg et al., 1991; Kerschmann et al., 1994; Stephenson et al., 1992; Lee and Teh, 1994; Schwartz, 1994) .
The genetic changes underlying KA are of interest for a number of reasons. Firstly, putative causal changes appear to be insufficient to allow the tumour to maintain its integrity and prolonged growth in the host; comparisons with the genetic changes found in SCC may therefore be interesting (Quinn et al., 1994b) . Secondly, a related tumour, the familial multiple self-healing squamous epithelioma (MSSE) of Ferguson-Smith, maps to chromosome 9q22-q31 (Goudie et al., 1993) . Although there may be histological differences between sporadic KA and MSSE, many consider the MSSE a form of familial KA (Straka and Grant-Kels, 1991; Schwartz, 1994) ; reports of multiple KAs occurring sporadically also suggest overlap (Witten and Zak, 1952) . A final reason for interest in the genetics of KAs is the finding that another cutaneous lesion, actinic keratoses (AK) (small scaly red lesions occurring on UVR-exposed skin showing varying degrees of dysplasia), which also show a high rate of spontaneous regression (Marks et al., 1986) , show a frequency of allelic loss similar to, if not higher than, SCC (Rehman et al., 1994) . One of a number of interpretations of the allelotype data of AK is that accumulation of genetic change in skin tumours may be associated with both progression and regression (Rees, 1994; Rehman et al., 1994 (Straka and Grant-Kels, 1991; Schwartz, 1994) . Paraffin-embedded sections (20 ,um) of tumour material (dewaxed) were microdissected from surrounding inflammatory infiltrate and normal skin on an inverted microscope. Tumour DNA and DNA from normal adjacent skin was isolated according to standard methods by proteinase K digestion and phenol -chloroform extraction (Jackson et al., 1992 (10 ,l) was added at the end of each reaction and samples were heat denatured and electrophoresed through 6% denaturing polyacrylamide gels. Gels were fixed in 10% acetic acid-10% methanol, vacuum dried and exposed to Fuji XR film for up to 24 h. Allelic loss was scored without knowledge of the putative tumour type and independently of the re-reviewed histological and clinical details. A significant reduction in the signal intensity of one of the two tumour alleles was recorded as LOH (although this does not formally exclude allelic imbalance secondary to amplification of one allele).
LOH analysis was carried out for loci that previous studies have shown to be frequently lost in SCC and AK (3p, 9p, 13q, 17p and 17q) (Quinn et al., 1994b; Rehman et al., 1994) , and on other arms chosen at random (see Table I ). Loci of markers are referred to as described by Weissenbach et al. (1992) . The frequency of LOH at a locus is given by the number of losses at the locus divided by the number of tumours informative for that locus. The fractional allelic loss (n = 11).
LOH in keratoacanthomas and basal cell papillomas The frequency of LOH for both KAs and benign papillomas was low with only isolated losses identified (Table I) . Of the 11 'definite KAs' only two tumours showed LOH occurring at a total of three loci; one KA showed allelic loss on chromosome arms 9p (D9S162) and 10q (D1OS185), one showed allelic loss on chromosome arm 9q (D9S160) (Figure  1 ), and the other nine KAs showed no LOH at any of the chromosome arms analysed. The FAL based on the 26 loci examined was 1.3% (3/228). Of the 27 BCPs studied LOH was identified in only two tumours; one showed LOH at 9q (D9S160) and the other at 17p (D17S796) (Figure 2 ). The FAL based on the 23 loci examined was 0.4% (2/453). Analysis of the 'probable KAs' (those that did not meet strict histological and clinical criteria) was also carried out. These 11 lesions showed a low frequency of loss with a FAL score based on the 26 loci examined of 2.2% (5/222) with LOH occurring at 3p (2/11), 9p (1/8), 17p (1/7) and 17q (1/7). By contrast, the one lesion recognised as a SCC showed LOH at 7 of 20 informative chromosome markers (3p, 3q, 9p, 9q, 1Oq, 17p and 18p).
Deletion mapping of chromosome 9 in the definite keratoacanthomas The pattern of chromosome 9 loss was examined in more detail in all 11 definite KAs using ten microsatellite markers. One KA showed loss of distal 9p markers D9S162 and D9S171 with retention of 9p markers centromeric to D9S171 and all informative 9q markers examined (D9S169, D9S166, D9S167, D9S152, D9S176 and D9S160). The area of loss in this lesion encompassed the interferon cluster at 9p21 -q22 and the region containing the genes coding for p16 and p15 (Olopade et al., 1992; Kamb et al., 1994; Nobori et al., 1994; Weaver-Feldhaus et al., 1994) . One other KA showed loss of 9q markers D9S160 and D9S176. However, attempts to further define the extent of loss of chromosome 9 in this lesion were impossible because analysis with other proximal 9q markers and 9p markers (D9S180, D9S152, D9S167 and D9S166, D9S165, D9S169, D9S171 and D9S162) was either uninformative or gave no PCR product. (Straka and Grant-Kels, 1991; Mackie, 1992; Schwartz, 1994) . Stephenson et al., 1992 Helander et al., 1993) . The only consistent difference lies in the characteristic clinical natural history of rapid growth followed by spontaneous involution of the KA compared with the persistence and possible metastasis of the SCC (Kwa et al., 1992) . A number of arguments have been advanced to explain the natural history of KAs, including that they are follicular tumours with the period of growth and involution reflecting the normal hair cycle periods of anagen and catagen; that involution is immunologically mediated; and that KAs are associated with genetic events (including ras mutations) that lead to regression rather than progression van der Meer, 1976, 1979; Ramselaar et al., 1980; Corominas et al., 1989; Straka and Grant-Kels, 1991; Patel et al., 1994; Schwartz, 1994) . There is support for and against each of these hypotheses and none of these explanations of KA involution is mutually exclusive.
The majority of KAs in the present study showed no LOH at any of the markers studied whereas LOH is common on chromosome arms 3p, 9p, 9q, 13q, 17p and 17q in SCCs and AKs. The FAL score for the KAs ('definite KAs') at these six loci of 4% (2/50) contrasts with the corresponding FAL score of 32% for the SCCs and 46% for the AKs (Quinn et al., 1994b; Rehman et al., 1994) . The results are also different from the 59% LOH seen on 9q for basal cell carcinomas (Quinn et al., 1994b) . The inclusion of only lesions that had both typical histological features and a characteristic clinical history in the KA group make it unlikely that the results are due to misdiagnosis of KAs as SCCs. The fact that a similar FAL score was seen in the 'probable KA' group is reassuring in this respect. Our previous findings showing a high frequency of LOH on chromosome 9 in basal cell Discussion carcinomas (Quinn et al., 1994b) , and a high FAL in AKs which are much smaller lesions than KAs (Rehman et al., 1994) , also argues against technical failure owing to an inability to separate tumour from stroma.
The rarity of LOH in KAs has bearings on their pathogenesis. Firstly it suggests that attempts to explain the involution of KAs on the basis that they are really SCCs that are for some other reason subsequently attacked by the immune system may be mistaken (Patel et al., 1994) . Secondly the failure to find LOH around the locus responsible for the MSSE syndrome is worthy of comment. There are differences of opinion about the nature of the tumours seen in MSSE with many authors referring to them as KAs, whereas others argue that they are a specific form of SCC that undergoes involution (Straka and Grant-Kels, 1991; Mackie, 1992; Ghadially and Ghadially, 1993; Schwartz, 1994 Ziegler et al., 1994) , as is the presence of p53 mutation (Campbell et al., 1993b; Brash et al., 1991; Ziegler et al., 1994) . This suggests a further difference between KA and SCCs, although it is not possible to exclude a role for p53 in KA as other methods of inactivating p53 may occur in KA; for instance mutations on both alleles of p53 as has been reported in BCC (Campbell et al., 1993a; Ziegler et al., 1993) , small deletions, or interaction with proteins that may target p53 degradation or interfere in the p53 pathway all of which could have been missed. Other studies have however failed to find p53 mutations in KAs (Kubo et al., 1994) .
The finding of occasional LOH in the BCPs and two of the KAs is open to a number of interpretations besides the obvious one that these changes are causally related to the pathogenesis of these lesions. Evidence of LOH does however suggest that these lesions are clonal. The fact that the two KAs showing LOH showed LOH on chromosome 9, and the involvement of loci on chromosome 9 in other forms of skin cancer, might be interpreted as support for these abnormalities being causally important in KA pathogenesis. Similarly in the 'probable KA' group LOH occurred at loci known to be lost at high frequency in SCC and AK, namely chromosome arms 3p, 9p, 17p and 17q. However, inevitably, interpretation of the probable KA results is difficult, as although most of the lesions are likely to represent KA, squamous cell carcinoma in one or more of the samples cannot be excluded, and the presence of SCC would clearly bias the results towards loss of those areas that occur in SCC development. An alternative, and perhaps less likely, hypothesis is that the LOH may be unrelated to the development of the lesion but merely reflects background LOH in the proliferative compartment in skin.
In summary the LOH data show a clear difference between KAs and SCCs. The interpretation of KAs as de novo squamous cell carcinomas which for some other reason involute seems unlikely, rather the results suggest that from early in their pathogenesis KAs are distinct from SCC. The low level of LOH in KAs contrasts with the predominantly isolated loss on chromosome 9 that occurs in basal cell carcinoma and the high frequency of LOH in lesions such as actinic keratoses that are also keratinocyte-derived and show a high rate of regression.
